Status:
COMPLETED
Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Abuse and Addiction
Eligibility:
All Genders
18-100 years
Brief Summary
The objective of this observational feasibility project is to assess the feasibility and acceptability of universal screening and measurement based care for opioid use disorder (OUD) utilizing a compu...
Detailed Description
This is an observational feasibility project evaluating the impact of universal screening and enhanced access to care for patients with opioid use disorder via development and implementation of web-ba...
Eligibility Criteria
Inclusion
- Providers and clinical staff from UTSW clinics currently utilizing the VitalSign6 software program
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 2 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04059016
Start Date
August 1 2019
End Date
May 2 2024
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75235